Events And
Presentations

B. Riley Fall 2021 Growth Biotech Best Ideas Series: Next-Gen Dual Agonist for Obesity and NASH

Oct 01, 2021

 

Investor Contact

Will Brown
Chief Financial Officer

Email: wbrown@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe